Mavidon, a Riviera Beach, Fla.-based medical devicemaker, warned hospitals and clinics Jan. 8 to stop using its LemonPrep, Pedia Prep, Wave Prep, Cardio Prep products, which are abrasive skin prepping lotions used to remove oils and skin residue on patients.
The products have the potential to be contaminated with Burkholderia cepacia, a multidrug resistant pathogenic microorganism. The bacteria can lead to serious infections and may be life-threatening for both immunocompromised patients as well as those who were previously healthy.
Mavidon has received one report of an adverse event in an infant due to bacterial contamination.
Hospitals and clinics should immediately stop using the products and quarantine them.
Read the full news release here.
More articles on supply chain:
Healthcare procurement pros unite, set up SHOPP
Medtronic files safety warning in UK over robotic system
Red Cross, NFL tackle blood shortages
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.